Uratuf (100+224) Mg Capsules: Tegafur and Uracil

Used to address colorectal cancer and other specific malignancies, this product contains Tegafur and Uracil. These compounds work together to interfere with the DNA replication process within rapidly dividing cells, effectively slowing their growth.

What Is Uratuf (100+224) Mg Capsules?

Uratuf (100+224) Mg Capsules represent a branded formulation containing Tegafur and Uracil as its active medicinal components. As a medication used in oncology, this combination serves as an antimetabolite, which is a type of medicine that mimics the building blocks of cells. By mimicking these blocks, the medicine interferes with the way cancer cells create the genetic material required to multiply.

Dr. Reddy’s Laboratories Ltd. manufactures this formulation, which is often associated with the well-known originator profile of UFT. While this product is used in specific oncology care plans, it functions by targeting the internal machinery that cancer cells rely on to grow, divide, and spread throughout the body.

How Is Uratuf (100+224) Mg Capsules Classified?

Across regulated markets including the United States, United Kingdom, Australia, and Canada, medications such as Tegafur and Uracil are strictly classified as prescription-only treatments. These agents require oversight from an oncology specialist, as their use is reserved for specific clinical protocols rather than general practice.

Because of the specialized nature of these capsules, individual access requirements can vary between these countries. In some regions, dispensing is restricted to hospital pharmacies or specialized outpatient cancer centers to ensure that every dose is administered under professional supervision. Local healthcare authorities set these guidelines to manage the use of high-potency treatments appropriately.

Uratuf (100+224) Mg Capsules: Form and Available Strengths

Uratuf (100+224) Mg Capsules are supplied as oral capsules, designed for precise administration as part of a prescribed regimen. The formulation consists of a fixed-dose combination of 100 mg of Tegafur and 224 mg of Uracil per capsule. This specific ratio is fundamental to how the medication reaches therapeutic levels in your system.

Dr. Reddy’s Laboratories Ltd. produces this medication to meet standardized quality benchmarks for oncology pharmaceuticals. If you have been prescribed this medicine, ensure you are using the specific strength directed by your healthcare team, as other combined oral therapies for similar conditions may contain different concentrations of these active compounds.

What Is Uratuf (100+224) Mg Capsules Used For?

This medication is primarily used to manage colorectal cancer, helping to control the progression of the disease by limiting the ability of cancerous tissues to proliferate. It may also be used for other types of cancer when prescribed by a specialist as part of a broader therapeutic plan.

The goal when using these capsules is to provide a targeted way to inhibit the survival of malignant cells while sparing healthy tissue as much as possible. Because this product is a powerful tool in oncology, it is used only when a patient’s specific condition and overall health profile indicate that the mechanism of Tegafur and Uracil provides the best balance for their treatment path.

How Do Tegafur and Uracil Work in Uratuf (100+224) Mg Capsules?

In the body, Tegafur slowly converts into fluorouracil, a chemical that stops cells from building DNA. Without the ability to synthesize DNA, cancer cells lose their capacity to replicate, which eventually forces them to stop growing or die off.

Uracil acts as a stabilizer in this duo. Normally, your body breaks down fluorouracil very quickly, which would make the treatment less effective. By including Uracil, the formulation blocks the enzymes responsible for that breakdown, allowing a higher concentration of the active medicine to remain present in your tissues for a longer period. This keeps the anti-cancer action consistent rather than having it spike and vanish too rapidly.

Where Uratuf (100+224) Mg Capsules Fits in Its Drug Class

These capsules belong to a class of medicines known as fluoropyrimidine antimetabolites. These agents are widely recognized in oncology for their ability to masquerade as the natural base molecules that cells use to build their genetic blueprint.

By occupying the space where legitimate cellular building blocks should go, these medicines force the cell to malfunction during the replication process. This class of medication has been a foundational part of oncological strategies for decades, providing a reliable way to address tumors that rely on rapid cell division to grow.

Safety Overview for Uratuf (100+224) Mg Capsules

What to check before using this medicine

Before starting this treatment, your medical team will evaluate your blood cell counts, liver function, and kidney health. It is essential to confirm that you do not have known hypersensitivities to fluoropyrimidines. Discuss your full medical history, including any previous cancer treatments or radiation, with your doctor to ensure this medicine is appropriate for your situation.

Possible reactions and tolerability

Common responses to this type of medication often relate to the rapid turnover of cells in your digestive tract and skin. You might experience changes in appetite, digestive discomfort, or sensitivity to the sun. Because this treatment acts systemically, your medical team will monitor you regularly to observe how your body tolerates the compound and to address any discomfort early.

Interactions and health factors

Many substances, including other medications, supplements, or dietary choices, can alter how your body processes this combination. Inform your healthcare provider about all treatments you are taking, particularly other chemotherapy agents or medicines that affect the immune system. Product labeling and verified clinical sources remain the correct references for specific contraindications, interactions, and potential reactions.

Finding Uratuf (100+224) Mg Capsules Online

• Patients in the United States, United Kingdom, Australia, and Canada search for product information through reputable health platforms and pharmacy directories before visiting their local specialist.
• Many individuals look for the specific manufacturer details to confirm they are accessing the intended formulation of Tegafur and Uracil.
• Comparing information on fixed-dose strengths helps patients better understand the details provided by their oncology team.
• Users often check if their specific pharmacy network carries this product to avoid extra trips during their treatment schedule.
• Searching for the originator brand, UFT, helps patients find clinical context or related labeling information.

Important Safety Information for Uratuf (100+224) Mg Capsules

Tegafur and Uracil, the active ingredients in Uratuf (100+224) Mg Capsules, are potent compounds intended only for use under expert medical supervision. Different formulations of fluoropyrimidines may contain varying strengths and have specific requirements for use. This page provides educational information only and does not authorize clinical application, self-directed interpretation, or unsupervised use. Please review your official product labeling, compare it with your own health situation, and speak with your healthcare professional when clinical judgment is required.